InnovationMap · Jun 2025
Summarizes the CPRIT round and notes Instapath as one of the Houston companies receiving a $900,000 product development research grant.
We built the world's first automated digital pathology lab.
Public company, workplace, funding, and market signals
Instapath Inc. is a Houston-based biotechnology/medical-device company founded in 2017 that builds slide-free digital pathology and fluorescence microscopy systems to speed cancer diagnosis while preserving tissue for downstream testing.
Primary product
Neo, a direct-to-digital fluorescence microscopy platform for fresh tissue pathology
Founded
2017
Headquarters
Houston, Texas, United States (2450 Holcombe Blvd Suite J, Houston, TX 77021)
Team size
1-10
Work style
Hybrid
Industry
Biotechnology Research
Sub-industry
Digital pathology / diagnostic equipment
Offices
0 jobs at Instapath Inc.
Check back later for new openings
Business model
Stage
seed
Total raised
$3.2M
Latest round
Grant · May 2025
Latest amount
$900K
Leadership
Co-founder and CEO
Co-founder and Chief Research Officer / Chief Scientific Officer
Co-founder and Chief Clinical Officer / Chief Operating Officer
Lead Product Engineer
Mission-driven and impact-oriented, with messaging focused on designing the future of cancer detection, improving patient outcomes, and working as a small hands-on engineering/science team.
Work style
Hybrid
Compensation
Intern roles are publicly posted at $15/hour for 10-30 hours per week; full-time roles advertise competitive salary.
Benefits
Pricing
Quote/demo-based with a customized service model for LuciNow and direct product sales for device/platform offerings.
Differentiators
Technology
Customers
Competitors
Estimated monthly visits
498
InnovationMap · Jun 2025
Summarizes the CPRIT round and notes Instapath as one of the Houston companies receiving a $900,000 product development research grant.
CPRIT · May 2025
CPRIT approved a $900,000 product development research award to Instapath Inc. for an automated digital pathology system for skin margin assessment.
NOLA.com · Jan 2025
Explains the ARPA-H project as a contract with milestones, including a prototype within two years and hospital-ready status by 2029.
Tulane News · Aug 2024
Announces the ARPA-H-funded MAGIC-SCAN project and says Instapath will help develop FDA-compliant versions of the scanner.
Tulane Murphy Institute · Aug 2024
Describes the up to $22.9 million ARPA-H award for Tulane's MAGIC-SCAN project and Instapath's role as a Tulane spinout partner.